APO RESEARCH · REPORT
Nuclear Medicine
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Product & engineering
Understand the product.
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Selected research
Industry Growth & Trends
Global Nuclear Medicine Industry Growth and Trends Forecast to 2032
Market perspective
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
According to APO Research, the global Nuclear Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Nuclear Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Nuclear Medicine market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nuclear Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nuclear Medicine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Nuclear Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Nuclear Medicine Market by Company
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
Nuclear Medicine Segment by Type
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Others
Nuclear Medicine Segment by Application
Diagnostic
Therapeutic
Nuclear Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Nuclear Medicine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Tc-99
- I-123/131
- In-111
- Xe-133
- Th-201
- Ga-67
- Others
Applications
- Diagnostic
- Therapeutic
Companies covered
- GE Healthcare
- Bracco Imaging
- Mallinckrodt
- Lantheus Medical Imaging
- Bayer
- Triad Isotopes
- Nordion
- Jubilant Pharma
- Eli Lilly
- SIEMENS
- China Isotope & Radiation
- Dongcheng
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Nuclear Medicine Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Nuclear Medicine Market Size by Region (2021-2032)
- 1.4.1 Global Nuclear Medicine Market Size by Region (2021-2026)
- 1.4.2 Global Nuclear Medicine Market Size by Region (2027-2032)
- 1.5 Key Regions Nuclear Medicine Market Size (2021-2032)
- 1.5.1 North America Nuclear Medicine Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Nuclear Medicine Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Nuclear Medicine Market Size Growth Rate (2021-2032)
- 1.5.4 South America Nuclear Medicine Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Nuclear Medicine Market Size Growth Rate (2021-2032)
2 Nuclear Medicine Market by Type
- 2.1 Type Introduction
- 2.1.1 Tc-99
- 2.1.2 I-123/131
- 2.1.3 In-111
- 2.1.4 Xe-133
- 2.1.5 Th-201
- 2.1.6 Ga-67
- 2.1.7 Others
- 2.2 Global Nuclear Medicine Market Size by Type
- 2.2.1 Global Nuclear Medicine Market Size Overview by Type (2021-2032)
- 2.2.2 Global Nuclear Medicine Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Nuclear Medicine Market Size Forecasted by Type (2027-2032)
- 2.3 Global Nuclear Medicine Market Size by Regions
- 2.3.1 North America Nuclear Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Nuclear Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Nuclear Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Nuclear Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Nuclear Medicine Market Size Breakdown by Type (2021-2026)
3 Nuclear Medicine Market by Application
- 3.1 Type Introduction
- 3.1.1 Diagnostic
- 3.1.2 Therapeutic
- 3.2 Global Nuclear Medicine Market Size by Application
- 3.2.1 Global Nuclear Medicine Market Size Overview by Application (2021-2032)
- 3.2.2 Global Nuclear Medicine Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Nuclear Medicine Market Size Forecasted by Application (2027-2032)
- 3.3 Global Nuclear Medicine Market Size by Regions
- 3.3.1 North America Nuclear Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Nuclear Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Nuclear Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Nuclear Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Nuclear Medicine Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Nuclear Medicine Industry Trends
- 4.2 Nuclear Medicine Industry Drivers
- 4.3 Nuclear Medicine Industry Opportunities and Challenges
- 4.4 Nuclear Medicine Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Nuclear Medicine Revenue (2021-2026)
- 5.2 Global Nuclear Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Nuclear Medicine Key Company Headquarters & Area Served
- 5.4 Global Nuclear Medicine Company, Product Type & Application
- 5.5 Global Nuclear Medicine Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Nuclear Medicine Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Nuclear Medicine Players Market Share by Revenue in 2025
- 5.6.3 2025 Nuclear Medicine Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 GE Healthcare
- 6.1.1 GE Healthcare Company Information
- 6.1.2 GE Healthcare Business Overview
- 6.1.3 GE Healthcare Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 GE Healthcare Nuclear Medicine Product Portfolio
- 6.1.5 GE Healthcare Recent Developments
- 6.2 Bracco Imaging
- 6.2.1 Bracco Imaging Company Information
- 6.2.2 Bracco Imaging Business Overview
- 6.2.3 Bracco Imaging Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Bracco Imaging Nuclear Medicine Product Portfolio
- 6.2.5 Bracco Imaging Recent Developments
- 6.3 Mallinckrodt
- 6.3.1 Mallinckrodt Company Information
- 6.3.2 Mallinckrodt Business Overview
- 6.3.3 Mallinckrodt Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Mallinckrodt Nuclear Medicine Product Portfolio
- 6.3.5 Mallinckrodt Recent Developments
- 6.4 Lantheus Medical Imaging
- 6.4.1 Lantheus Medical Imaging Company Information
- 6.4.2 Lantheus Medical Imaging Business Overview
- 6.4.3 Lantheus Medical Imaging Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Lantheus Medical Imaging Nuclear Medicine Product Portfolio
- 6.4.5 Lantheus Medical Imaging Recent Developments
- 6.5 Bayer
- 6.5.1 Bayer Company Information
- 6.5.2 Bayer Business Overview
- 6.5.3 Bayer Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Bayer Nuclear Medicine Product Portfolio
- 6.5.5 Bayer Recent Developments
- 6.6 Triad Isotopes
- 6.6.1 Triad Isotopes Company Information
- 6.6.2 Triad Isotopes Business Overview
- 6.6.3 Triad Isotopes Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Triad Isotopes Nuclear Medicine Product Portfolio
- 6.6.5 Triad Isotopes Recent Developments
- 6.7 Nordion
- 6.7.1 Nordion Company Information
- 6.7.2 Nordion Business Overview
- 6.7.3 Nordion Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Nordion Nuclear Medicine Product Portfolio
- 6.7.5 Nordion Recent Developments
- 6.8 Jubilant Pharma
- 6.8.1 Jubilant Pharma Company Information
- 6.8.2 Jubilant Pharma Business Overview
- 6.8.3 Jubilant Pharma Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Jubilant Pharma Nuclear Medicine Product Portfolio
- 6.8.5 Jubilant Pharma Recent Developments
- 6.9 Eli Lilly
- 6.9.1 Eli Lilly Company Information
- 6.9.2 Eli Lilly Business Overview
- 6.9.3 Eli Lilly Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Eli Lilly Nuclear Medicine Product Portfolio
- 6.9.5 Eli Lilly Recent Developments
- 6.10 SIEMENS
- 6.10.1 SIEMENS Company Information
- 6.10.2 SIEMENS Business Overview
- 6.10.3 SIEMENS Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 SIEMENS Nuclear Medicine Product Portfolio
- 6.10.5 SIEMENS Recent Developments
- 6.11 China Isotope & Radiation
- 6.11.1 China Isotope & Radiation Company Information
- 6.11.2 China Isotope & Radiation Business Overview
- 6.11.3 China Isotope & Radiation Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 China Isotope & Radiation Nuclear Medicine Product Portfolio
- 6.11.5 China Isotope & Radiation Recent Developments
- 6.12 Dongcheng
- 6.12.1 Dongcheng Company Information
- 6.12.2 Dongcheng Business Overview
- 6.12.3 Dongcheng Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Dongcheng Nuclear Medicine Product Portfolio
- 6.12.5 Dongcheng Recent Developments
7 North America
- 7.1 North America Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Nuclear Medicine Market Size by Country (2021-2026)
- 7.3 North America Nuclear Medicine Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Nuclear Medicine Market Size by Country (2021-2026)
- 8.3 Europe Nuclear Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Nuclear Medicine Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Nuclear Medicine Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Nuclear Medicine Market Size by Country (2021-2026)
- 10.3 South America Nuclear Medicine Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Nuclear Medicine Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Nuclear Medicine Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst